These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 11990087

  • 1. Arylpiperazine derivatives of 3-propyl-beta-tetralonohydantoin as new 5-HT1A and 5-HT2A receptor ligands.
    Byrtus H, Pawłowski M, Duszyńska B, Wesołowska A, Chojnacka-Wójcik E, Bojarski AJ.
    Pol J Pharmacol; 2001; 53(4):395-401. PubMed ID: 11990087
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, 5-HT1A and 5-HT2A receptor activity of new 1-phenylpiperazinylpropyl derivatives with arylalkyl substituents in position 7 of purine-2,6-dione.
    Chloń G, Pawłowski M, Duszyńska B, Szaro A, Tatarczńska E, Kłodzińska AL, Chojnacka-Wójcik E.
    Pol J Pharmacol; 2001; 53(4):359-68. PubMed ID: 11990082
    [Abstract] [Full Text] [Related]

  • 3. Substitution mode of the amide fragment in some new N-[omega-[4-(2-methoxyphenyl)piperazin-1-yl]alkyl]pyrid-2(1H)-ones and their 5-HT1A/5-HT2A activity.
    Paluchowska MH, Bugno R, Charakchieva-Minol S, Bojarski AJ, Wesołowska A.
    Pol J Pharmacol; 2001; 53(4):369-76. PubMed ID: 11990083
    [Abstract] [Full Text] [Related]

  • 4. 2-H- and 2-acyl-9- [omega-[4-(2-methoxyphenyl)piperazinyl]-alkyl]-1,2,3,4-tetrahydro-beta-carbolines as ligands of 5-HT1A and 5-HT2A receptors.
    Boksa J, Mokrosz MJ, Charakchieva-Minol S, Tatarczyńska E, Kłodzińska A, Wesołowska A, Misztal S.
    Pol J Pharmacol; 2001; 53(5):501-8. PubMed ID: 11990069
    [Abstract] [Full Text] [Related]

  • 5. 1,4-Benzoxazin-3(4H)-one derivatives and related compounds as 5-HT1A and 5-HT2A receptor ligands; the effect of the terminal amide fragment on the 5-HT1A/5-HT2A affinity and functional activity.
    Mokrosz MJ, Kowalski P, Kowalska T, Majka Z, Duszyńska B, Charakchieva-Minol S, Szaro A, Tatarczyńska E, Kłodzińska A, Chojnacka-Wójcik E.
    Pol J Pharmacol; 1998; 50(4-5):333-40. PubMed ID: 10091718
    [Abstract] [Full Text] [Related]

  • 6. 9-substituted 1,2,3,4-tetrahydro-beta-carbolin-1-ones, new 5-HT1A and 5-HT2A receptor ligands.
    Mokrosz MJ, Boksa J, Charakchieva-Minol S, Wesołowska A, Borycz J.
    Pol J Pharmacol; 1999; 51(4):351-6. PubMed ID: 10540967
    [Abstract] [Full Text] [Related]

  • 7. Novel 4-alkyl-1-arylpiperazines and 1,2,3,4-tetrahydroisoquinolines containing diphenylmethylamino or diphenylmethoxy fragment with differentiated 5-HT1A/5-HT2A/D2 receptor activity.
    Paluchowska MH, Mokrosz MJ, Charakchieva-Minol S, Duszyńska B, Kozioł A, Wesołowska A, Stachowicz K, Chojnacka-Wójcik E.
    Pol J Pharmacol; 2003; 55(4):543-52. PubMed ID: 14581712
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and 5-HT1A/5-HT2A receptor activity of new N-[3-(4-phenylpiperazin-1-yl)-propyl] derivatives of 3-spiro-cyclohexanepyrrolidine-2,5-dione and 3-spiro-beta-tetralonepyrrolidine-2,5-dione.
    Obniska J, Pawłowski M, Kołaczkowski M, Czopek A, Duszyńska B, Klodzińska A, Tatarczyńska E, Chojnacka-Wójcik E.
    Pol J Pharmacol; 2003; 55(4):553-7. PubMed ID: 14581713
    [Abstract] [Full Text] [Related]

  • 9. New 4-[omega-(diarylmethylamino)alkyl]- and 4-[omega-(diarylmethoxy)alkyl]-1-arylpiperazines as selective 5-HT1A/5-HT2A receptor ligands with differentiated in vivo activity.
    Paluchowska MH, Charakchieva-Minol S, Tatarczyńska E, Kłodzińska A, Stachowicz K, Chojnacka-Wójcik E.
    Pol J Pharmacol; 2004; 56(6):743-54. PubMed ID: 15662087
    [Abstract] [Full Text] [Related]

  • 10. Effect of the amide fragment on 5-HT1A receptor activity of some analogs of MP 3022.
    Paluchowska MH, Charakchieva-Minol S, Tatarczyńska E, Kłodzińska A.
    Pol J Pharmacol; 1999; 51(5):415-21. PubMed ID: 10817542
    [Abstract] [Full Text] [Related]

  • 11. Synthesis of new hexahydro- and octahydropyrido[1,2-c]pyrimidine derivatives with an arylpiperazine moiety as ligands for 5-HT1A and 5-HT2A receptors. Part 4.
    Herold F, Król M, Kleps J, Nowak G.
    Eur J Med Chem; 2006 Jan; 41(1):125-34. PubMed ID: 16263195
    [Abstract] [Full Text] [Related]

  • 12. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics.
    Bojarski AJ, Paluchowska MH, Duszyńska B, Kłodzińska A, Tatarczyńska E, Chojnacka-Wójcik E.
    Bioorg Med Chem; 2005 Mar 15; 13(6):2293-303. PubMed ID: 15727878
    [Abstract] [Full Text] [Related]

  • 13. Synthesis, in vitro and in vivo 5-HT1A/5-HT2A serotonin receptor activity of new hybrid 1,2,3,4-tetrahydro-gamma-carbolines with 1-(2-methoxyphenyl)piperazine moiety.
    Boksa J, Charakchieva-Minol S, Duszyńska B, Bugno R, Kłodzińska A, Tatarczyńska E, Chojnacka-Wójcik E, Bojarski AJ.
    Pol J Pharmacol; 2003 Mar 15; 55(6):1013-9. PubMed ID: 14730096
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and in vitro pharmacological evaluation of a new series of 5-HT1A 5-HT2A and 5-HT2C receptor ligands containing a norbornene nucleus.
    Fiorino F, Severino B, De Angelis F, Perissutti E, Magli E, Frecentese F, Esposito A, Massarelli P, Nencini C, Viti B, Santagada V, Caliendo G.
    Pharmazie; 2009 Sep 15; 64(9):555-64. PubMed ID: 19827295
    [Abstract] [Full Text] [Related]

  • 15. Novel N-[omega-[4-(2-methoxyphenyl)piperazin-1-yl]-ethyl]pyrid-2(1H)-ones with diversified 5-HT1A receptor activity.
    Paluchowska MH, Bugno R, Charakchieva-Minol S, Wesołowska A, Chojnacka-Wójcik E.
    Pol J Pharmacol; 2002 Sep 15; 54(6):641-6. PubMed ID: 12866719
    [Abstract] [Full Text] [Related]

  • 16. Effect of linking bridge modifications on the 5-HT1A receptor activity of some 4-(omega-benzotriazol-1-yl)alkyl-1-(2-methoxy-phenyl)piperazines.
    Paluchowska MH, Kłodzińska A, Tatarczyńska E, Szaro A, Chojnacka-Wójcik E.
    Pol J Pharmacol; 1998 Sep 15; 50(4-5):341-7. PubMed ID: 10091719
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and 5-HT1A/5-HT2A activity of some butyl analogs in the group of phenylpiperazine alkyl pyrimido[2,1-f]theophyllines.
    Kołaczkowski M, Zajdel P, Fhid O, Duszyńska B, Tatarczyńska E, Pawłowski M.
    Pharmacol Rep; 2005 Sep 15; 57(2):229-35. PubMed ID: 15886422
    [Abstract] [Full Text] [Related]

  • 18. Novel class of arylpiperazines containing N-acylated amino acids: their synthesis, 5-HT1A, 5-HT2A receptor affinity, and in vivo pharmacological evaluation.
    Zajdel P, Subra G, Bojarski AJ, Duszyńska B, Tatarczyńska E, Nikiforuk A, Chojnacka-Wójcik E, Pawłowski M, Martinez J.
    Bioorg Med Chem; 2007 Apr 15; 15(8):2907-19. PubMed ID: 17321139
    [Abstract] [Full Text] [Related]

  • 19. Structure-activity relationship studies of CNS agents, Part 20: 9-(omega-[1-(m-chlorophenyl)-4-piperazinyl]alkyl]-1,2,3,4-tetra-hydro- beta-carbolines: new 5-HT1A and 5-HT2A receptor ligands.
    Boksa J, Duszynńska B, Mokrosz JL.
    Pharmazie; 1995 Mar 15; 50(3):220-1. PubMed ID: 7732057
    [No Abstract] [Full Text] [Related]

  • 20. Synthesis and 5-HT(1A), 5-HT(2A) receptor activity of new beta-tetralonohydantoins.
    Byrtus H, Pawłowski M, Czopek A, Bojarski AJ, Duszyńska B, Nowak G, Kłodzińska A, Tatarczyńska E, Wesołowska A, Chojnacka-Wójcik E.
    Eur J Med Chem; 2005 Aug 15; 40(8):820-9. PubMed ID: 16122584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.